Teva Branded Pharmaceutical Products R&d Llc

This study tested a new drug called modakafusp alfa, given through a vein, in combination with other treatments for adults with multiple myeloma. The goal was to find the safest dose and check for side effects. The trial was stopped early, and only 15 people were enrolled.

This study tested a new drug (modakafusp alfa) combined with an existing one (daratumumab) in 15 people whose multiple myeloma had returned or stopped responding to treatment. The main goals were to check safety and find the best dose. The study was stopped early, so results are …

This study tested an experimental drug called modakafusp alfa in people with multiple myeloma that had returned or stopped responding to at least three prior treatments. The goal was to find a safe dose and see if the drug could shrink tumors. The trial was stopped early, but the…

This study tested a new drug called modakafusp alfa, alone or with pembrolizumab, in 45 adults with advanced solid tumors or melanoma that couldn't be removed by surgery. The main goals were to check safety and find the best dose. The study was terminated early, so results are li…